These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 23254773)
21. Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes. Kim HJ; Yonezawa T; Teruya T; Woo JT; Cha BY Photochem Photobiol; 2015; 91(2):379-86. PubMed ID: 25488359 [TBL] [Abstract][Full Text] [Related]
22. [Regulation of melanogenesis: the role of cAMP and MITF]. Otręba M; Rok J; Buszman E; Wrześniok D Postepy Hig Med Dosw (Online); 2012 Jan; 66():33-40. PubMed ID: 22371403 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of melanogenesis by 3-(1'-methyltetrahydropyridinyl)-2,4-6-trihydroxy acetophenone via suppressing the activity of cAMP response element-binding protein (CREB) and nuclear exclusion of CREB-regulated transcription coactivator 1 (CRTC1). Naikoo SH; Rashid H; Kumar S; Archoo S; Sheikh UA; Lone NA; Singh PP; Tasduq SA Eur J Pharmacol; 2023 Aug; 952():175734. PubMed ID: 37080332 [TBL] [Abstract][Full Text] [Related]
24. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways. Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280 [TBL] [Abstract][Full Text] [Related]
25. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways. Shimoda H; Shan SJ; Tanaka J; Maoka T J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone. Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175 [TBL] [Abstract][Full Text] [Related]
27. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation. Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124 [No Abstract] [Full Text] [Related]
28. Anti-melanogenic effects of resorcinol are mediated by suppression of cAMP signaling and activation of p38 MAPK signaling. Kang M; Park SH; Oh SW; Lee SE; Yoo JA; Nho YH; Lee S; Han BS; Cho JY; Lee J Biosci Biotechnol Biochem; 2018 Jul; 82(7):1188-1196. PubMed ID: 29621941 [TBL] [Abstract][Full Text] [Related]
29. Glucosamine abrogates the stem cell factor + endothelin-1-induced stimulation of melanogenesis via a deficiency in MITF expression due to the proteolytic degradation of CREB in human melanocytes. Niwano T; Terazawa S; Sato Y; Kato T; Nakajima H; Imokawa G Arch Dermatol Res; 2018 Oct; 310(8):625-637. PubMed ID: 30046896 [TBL] [Abstract][Full Text] [Related]
30. Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Saha B; Singh SK; Sarkar C; Bera R; Ratha J; Tobin DJ; Bhadra R Pigment Cell Res; 2006 Dec; 19(6):595-605. PubMed ID: 17083486 [TBL] [Abstract][Full Text] [Related]
31. Globular adiponectin acts as a melanogenic signal in human epidermal melanocytes. Kim Y; Cho JY; Oh SW; Kang M; Lee SE; Jung E; Park YS; Lee J Br J Dermatol; 2018 Sep; 179(3):689-701. PubMed ID: 29485733 [TBL] [Abstract][Full Text] [Related]
32. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. Huber WE; Price ER; Widlund HR; Du J; Davis IJ; Wegner M; Fisher DE J Biol Chem; 2003 Nov; 278(46):45224-30. PubMed ID: 12944398 [TBL] [Abstract][Full Text] [Related]
33. CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression. Liang H; Fekete DM; Andrisani OM Mol Cell Biol; 2011 Mar; 31(5):955-70. PubMed ID: 21199918 [TBL] [Abstract][Full Text] [Related]
34. Atraric Acid Ameliorates Hyperpigmentation through the Downregulation of the PKA/CREB/MITF Signaling Pathway. Li J; Jiang S; Huang C; Yang X Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555593 [TBL] [Abstract][Full Text] [Related]
35. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP. Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095 [TBL] [Abstract][Full Text] [Related]
36. Glycine hydroxamate inhibits tyrosinase activity and melanin contents through downregulating cAMP/PKA signaling pathways. Lin YS; Wu WC; Lin SY; Hou WC Amino Acids; 2015 Mar; 47(3):617-25. PubMed ID: 25501504 [TBL] [Abstract][Full Text] [Related]
37. Aqueous fraction from Cuscuta japonica seed suppresses melanin synthesis through inhibition of the p38 mitogen-activated protein kinase signaling pathway in B16F10 cells. Jang JY; Kim HN; Kim YR; Choi YH; Kim BW; Shin HK; Choi BT J Ethnopharmacol; 2012 May; 141(1):338-44. PubMed ID: 22414478 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061 [TBL] [Abstract][Full Text] [Related]
39. Nuclear Entry of CRTC1 as Druggable Target of Acquired Pigmentary Disorder. Yun CY; Hong SD; Lee YH; Lee J; Jung DE; Kim GH; Kim SH; Jung JK; Kim KH; Lee H; Hong JT; Han SB; Kim Y Theranostics; 2019; 9(3):646-660. PubMed ID: 30809299 [No Abstract] [Full Text] [Related]
40. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation. Lee CS; Park M; Han J; Lee JH; Bae IH; Choi H; Son ED; Park YH; Lim KM J Invest Dermatol; 2013 Apr; 133(4):1063-71. PubMed ID: 23223141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]